NCT04077879View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

June 12, 2021

Study Completion Date

June 12, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

ASP1617

Oral

DRUG

Placebo

Oral

Trial Locations (1)

91206

California Clinical Trials Medical Group / Parexel, Glendale

All Listed Sponsors

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT04077879 - Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect | Biotech Hunter | Biotech Hunter